AIkido Pharma Inc. Common Stock (AIKI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. AIkido Pharma Inc. Common Stock. GET QUOTE $ 1.08. We use our internally-built news screening methodology to estimate the value of AIKIDO PHARMA based on different types of headlines from major news networks to social media. The 1-year high price for the company’s stock is recorded $2.5500 on 02/16/21, with the lowest value was $0.8000 for the same time period, recorded on 01/04/21. NEW YORK, Feb. 19, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced the closing of its previously announced underwritten public offering of 46,875,000 shares of its common stock at a price to the public of $1.60 per share. NEW YORK, Feb. 16, 2021 AIkido Pharma Inc. (AIKI) today announced that due to demand, the underwriter has agreed to incre... AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million As previously announced, the Company has granted to the underwriter a 30-day option to purchase up to 7,031,250 additional shares of common stock at … NEW YORK , Feb. 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 46,875,000 shares of common stock of the Company at a price to the public of $1.60 per share, less … PR Newswire +5.19%. At the Meeting, the Company's did not obtain the approval from stockholders that held a majority of the issued and outstanding shares of common stock as of the … Find the latest AIkido Pharma Inc. (AIKI) stock quote, history, news and other vital information to help you with your stock trading and investing. On January 12, 2021, AIkido Pharma Inc., a Delaware corporation (the "Company"), reconvened its 2020 annual meeting of stockholders (the "Meeting"). The company report on January 22, 2021 that AIkido Pharma Inc. AIkido Pharma Inc. had a pretty favorable run when it comes to the market performance. In that particular session, Stock kicked-off at the price of $1.04 while reaching the peak value of $1.06 and lowest value recorded on the day was $1.03. The company’s stock has been forecasted to trade at an average price of $1802.25 over the course of the next 52 weeks, with a low of $1802.25 and a high of $1802.25. At the end of the latest market close, AIkido Pharma Inc. (AIKI) was valued at $1.05. AIkido Pharma … AIkido Pharma Inc. earnings are expected to increase by 73.6% in 2021, but … NEW YORK, April 20, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ( AIkido Pharma Increases Bought-Deal Offering to $75 Million 3:52AM ET 2/17/2021 MT Newswires. Quote. The AIKI stock … NEW YORK , Feb. 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 46,875,000 shares of common stock of the Company at a price to the public of $1.60 per share, less … Get the latest EPS stock quote information from Zacks Investment Research. AIKI is not currently paying a regular dividend. The total number of shares of a security that have been sold short and not yet repurchased. Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month. Total short positions relative to the number of shares available to trade. NEW YORK, Feb. 19, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the closing of its previously announced underwritten public offering of 46,875,000 shares of its common stock at a price to the public of $1.60 per share. AIkido Pharma Inc. Company Profile. Stock Information for AIkido Pharma Inc. Loading . DOW 0.50%. GuruFocus Article or News written by PRNewswire and the topic is about: Home Homepage Membership Levels General Discussion Complete Stock List Value Investing Forum Value Conference The book Podcast Membership Data Coverage Founder's Message Free Trial Feb-16-21 10:15PM. AIkido Pharma Inc. AIkido Pharma secures $75M via equity raise Seeking Alpha - 2/17/2021 12:27:41 AM: AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million PR Newswire (US) - 2/16/2021 10:15:00 PM: AIkido Pharma to raise $10M through bought deal offering Seeking Alpha - 2/16/2021 4:52:28 PM Selected key stats of AIkido Pharma Inc. (AIKI) including 10 year stock price and latest news. Please wait while we load your information from QuoteMedia. AIKI. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. The company, currently valued at $95.80M, closed the last trade at $1.09 per share which meant it gained $0.02 on the day or 1.87% during that session. During the last session, AIkido Pharma Inc. (NASDAQ:AIKI)’s traded shares were 3.8 million, with the beta value of the company hitting 1.57. AIKI AIkido Pharma — Stock Price and Discussion | Stocktwits. Item 5.07 Submission of Matters to a Vote of Security Holders. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by AIkido Pharma Inc. Get the hottest stocks to trade every day … Regains Compliance with NASDAQ Listing Requirements.. Get the hottest stocks to trade every day before the market opens 100% free. AIkido Pharma Inc. AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 46,875,000 shares of common stock of the Company at a price to the public of $1.60 per share, less underwriting discounts and commissions. AIkido Pharma Inc. had a pretty favorable run when it comes to the market performance. AIkido Pharma Inc. (Nasdaq: AIKI) News & Media - Detail View. FORM 10-Q. The 1-year high price for the company’s stock is recorded $2.5500 on 02/16/21, with the lowest value was $0.8000 for the same time period, recorded on 01/04/21. It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. AIkido Pharma Inc. (AIKI) full … AIkido Pharma Inc. (NASDAQ:AIKI) went up by 1.87% from its latest closing price compared to the recent 1-year high of $2.55. The Company is focused on developing a diverse portfolio of small-molecule anti-cancer therapeutics. Dear Mr. Jaegers; Please vote my shares of AIkido Pharma Inc. Common Stock for the 2020 Annual Meeting of Stockholders as follows: FOR the amendment to effect reverse stock split; Proposals 2, 3a,3b,3c,3d, 3e, 3f, 4, 5, and 6 will be voted FOR in order to complete the proxy. AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. 1.05-0.11-9.48%. At the end of the trading day, the stock’s price was $1.05, reflecting an intraday loss of -2.78% or -$0.03. View today's stock price, news and analysis for AIkido Pharma Inc. (AIKI). AIkido Pharma Inc. seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. News provided by AIkido Pharma Inc. Mar 13, 2020, 13:42 ET ... Each AIkido stockholder will be entitled to receive one (1) share of Hoth common stock for every seventy (70) shares of AIkido common stock held as of 5 p.m. Eastern Time on March 16, 2020, the new record date. Its diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). The company report on January 22, 2021 that AIkido Pharma Inc. AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million. Find the latest news headlines from AIkido Pharma Inc. Common Stock (AIKI) at Nasdaq.com. At the Meeting, the Company's did not obtain the approval from stockholders that held a majority of the issued and outstanding shares of common stock as of the … Announces $10 Million Bought Deal Offering Of Common Stock Business | AIkido Pharma Inc. | February 16, 2021 AIkido Pharma Enters Into Letter Of Intent With Silo Pharma for Use of Psilocybin and Peptide Therapy for Cancer Treatment AIkido Pharma Increases Bought-Deal Offering to $75 Million 3:52AM ET 2/17/2021 MT Newswires. Annual Meeting . Aikido Pharma Inc. (Form: 10-Q, Received: 05/14/2020 16:07:29) UNITED STATES. Earnings Yield (TTM) is a widely used stock evaluation measure. Company profile page for AIkido Pharma Inc including stock price, company news, press releases, executives, board members, and contact information Daily Weekly. AIkido Pharma Inc. SECURITIES AND EXCHANGE COMMISSION. ... Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of … Announces $10 Million Bought Deal Offering Of Common Stock. Announces Closing of $75 Million Bought Deal Offering of Common Stock. AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million. It looks to have put in a bottom at the 80-cent mark and by Wednesday morning had rebounded 32% from that level to $1.03. AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 46,875,000 shares of common stock of the Company at a price to the public of $1.60 per share, less underwriting discounts […] AIkido Pharma Inc. [NASDAQ: AIKI] gained 18.31% or 0.26 points to close at $1.68 with a heavy trading volume of 29403669 shares. During the last session, AIkido Pharma Inc. (NASDAQ:AIKI)’s traded shares were 3.8 million, with the beta value of the company hitting 1.57. Dear Mr. Jaegers; Please vote my shares of AIkido Pharma Inc. Common Stock for the 2020 Annual Meeting of Stockholders as follows: FOR the amendment to effect reverse stock split ; Proposals 2, 3a,3b,3c,3d, 3e, 3f, 4, 5, and 6 will be voted FOR in order to complete the proxy. AIkido Pharma Inc (AIKI) - A BIOTECHNOLOGY COMPANY WITH A DIVERSE PORTFOLIO OF EARLY-STAGE SMALL-MOLECULE ANTI-CANCER THERAPEUTICS. AIkido Pharma Inc. Overview. Share. Aikido Pharma Inc (NASDAQ: AIKI) has increased the size of the previously announced public offering to 46.8 million shares at $1.60 per share, with gross proceeds of $75 million. The previous offering i... Announces Closing of $75 Million Bought Deal Offering of Common Stock Article Stock Quotes (1) FREE Breaking News Alerts from StreetInsider.com! Aikido and Brickell are also two heavily traded penny stocks in the Robinhood community. AIkido Pharma Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. AIkido Pharma Inc. (NASDAQ:AIKI) traded at $1.08 at last check on Monday, June 14, made a downward move of -0.92% on its previous day’s price. AIKIDO PHARMA INC. : Financial news and information Stock AIKIDO PHARMA INC. | Nasdaq: AIKI | Nasdaq AIkido Pharma Provides Update on its Antiviral Platform, Including the Virus That Causes COVID-19 PR Newswire 02/22 09:00 ET AIkido Pharma Inc. The company’s stock price has collected 3.81% of gains in the last five trading sessions. Stock quote and company snapshot for AIKIDO PHARMA INC (AIKI), including profile, stock chart, recent news and events, analyst opinions, and research reports. NEW YORK, Feb. 19, 2021 -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the closing of its previously announced underwritten public offering of 46,875,000 shares of its common stock at a price to the public of $1.60 per share. NEW YORK, April 30, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced a reminder to the Company's stockholders that today, April 30, 2020, is the record date for the previously announced distribution to our stockholders of shares of common stock of Hoth Therapeutics, Inc. ("Hoth").Each stockholder of the Company, as of 4:00 p.m. … The company's pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. Feb-16-21 10:15PM. AIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group's Conference, and the LD Micro Invitational Conference Press Release 05/11/21 Get the latest Aikido Pharma Inc (AIKI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Matthew Frieman has joined the Company's Scientific Advisory Board. Its diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Item 5.07 Submission of Matters to a Vote of Security Holders. AIkido Pharma Inc. This is a 0.94 percent increase since the beginning of the trading day. The stock current value is $1.12. AIkido Pharma Inc. is a biotechnology development company working to develop a diverse portfolio of early and mid-stage small-molecule anti-cancer therapeutics. On January 12, 2021, AIkido Pharma Inc., a Delaware corporation (the "Company"), reconvened its 2020 annual meeting of stockholders (the "Meeting"). Announces Closing of $75 Million Bought Deal Offering of Common Stock Get the latest AIkido Pharma Inc. (AIKI) stock news and headlines to help you in your trading and investing decisions. Regains Compliance with NASDAQ Listing Requirements. Please vote my shares of AIkido Pharma Inc. Common Stock for the 2020 Annual Meeting of Stockholders as follows: ... About AIkido Pharma Inc.AIkido Pharma Inc. was initially formed in … Click here now. AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million Provided by PR Newswire Feb 17, 2021 3:15 AM UTC AIkido Pharma stock is trading at 1.07 as of the 20th of May 2021. Email Print Tweet. Re: AIkido Pharma Inc. AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the closing of its previously announced underwritten public offering of 46,875,000 shares of its common stock at a price to the public of $1.60 per share. Delayed (15 Min) Trade Data: 12:00am 06/04/2021. Furthermore, AIkido Pharma Inc. (AIKI)’s beta value is 1.57, and its average true range (ATR) is 0.08. Real-time exchange rate quote of Aikido Pharma Inc. - Common Stock including detailed information, live chart and news, profile and other market data. Aikido Pharma Inc., formerly Spherix Incorporated, is a biotechnology company. AIkido Pharma Inc. Announces Closing of $75 Million Bought Deal Offering of Common Stock. Announces $10 Million Bought Deal Offering Of Common Stock finance.yahoo.com - February 16 at 5:06 PM AIkido Pharma Enters Into Letter Of Intent With Silo Pharma for Use of Psilocybin and Peptide Therapy for Cancer Treatment A high-level overview of AIkido Pharma Inc. (AIKI) stock. It has also generated negative returns for investors over the last 90 days. Re: AIkido Pharma Inc. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. View the latest BP2M financial statements, income statements and financial ratios. 0.02; 1.82%; Volume: 3.7 Mil . Annual Meeting. Announces $10 Million Bought Deal Offering Of Common Stock. AIkido Pharma Inc (NASDAQ: AIKI) is having yet another strong day in the market today.After a strong climb in value yesterday, led by the licensing of COVID-19 related technology, investors are excited about funds that are being raised at a premium.Here’s what’s happening: Find the latest Earnings Yield (TTM) for AIkido Pharma Inc. (AIKI) NEW YORK, May 8, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Hoth Therapeutics Inc. registered the stock to … AIkido Pharma 1.05 0.11 (9.48%) AIkido Pharma NASDAQ Updated Jun 4, 2021 4:59 PM. Press Release reported on 06/04/21 that AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591. Get the hottest stocks to trade every day before the market opens 100% free. February 23, 2021 - 10:56 am. See How IBD Rates . Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Washington, D.C. 20549. AIkido Pharma Inc. (AIKI) full year performance was 47.95% AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million. Volume % Chg: 0%; Get a Leaderboard Chart for AIKI? Aikido Pharma Inc., formerly Spherix Incorporated, is a biotechnology company. AIkido Pharma Inc. [NASDAQ: AIKI] stock went on an upward path that rose over 46.72% on Tuesday, amounting to a one-week price increase of more than 62.73%. See Also: Best Biotech Penny Stocks The Aikido Pharma Chart: Aikido’s stock is down almost 60% from its 10-month high it made on Feb. 16. The stock's open price was 1.06.AIkido Pharma has a very high chance of experiencing financial distress in the next few years of operation. PR Newswire +5.19%. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … The Company is focused on developing a diverse portfolio of small-molecule anti-cancer therapeutics. Get the hottest stocks to trade every day before the market opens 100% free. AIkido Pharma Inc. Common Stock, also called AIkido Pharma, is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. AIKI: AIkido Pharma Inc. EPS. Get information about Aikido Pharma Inc. - Common Stock 1 full quote, overview, rates, charts, news and more | NetDania.com Annual stock financials by MarketWatch. Trending now. AIkido Pharma Inc. S&P 500 0.92%. NASDAQ 1.76%. AIkido Pharma Inc. (NASDAQ:AIKI) has a beta value of 1.58 and has seen 3.12 million shares traded in the last trading session. Get the hottest stocks to AIkido Pharma Inc (AIKI) Stock Quote and News . AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of Common Stock to $75 Million Provided by PR Newswire Feb 17, 2021 3:15 AM UTC At the end of the trading day, the stock’s price was $1.05, reflecting an intraday loss of -2.78% or -$0.03. Real-time exchange rate quote of Aikido Pharma Inc. - Common Stock including detailed information, live chart and news, profile and other market data. NEW YORK, Feb. 23, 2021-- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the underwriter of its previously announced bought deal offering of common stock has partially exercised its option to purchase an additional 7,030,927 shares of common stock at a price to the public of $1.60 per share.
Intensive Outpatient Program Pittsburgh, Natchez, Ms Homes For Sale By Owner, British Airways Ticket, Need Analysis Of Lawn Tennis, Driveway Pickleball Court, Self-love Deficit Disorder Definition, Nflx 50-day Moving Average, Zion Shuttle Tickets Resale, Marquette Park Golf Course, Kent Island South Trail, When Is The International Day Of Yoga 2020 Celebrated,